Learn more about investing in QuantumCyte

Our team will get back to you soon to follow up on your inquiry.
Opt-In Checkbox
We don’t spam. Our Privacy Policy and Cookie Policy apply. The site is protected by reCAPTCHA.
QuantumCyte
Answers from every biopsy
Founded
2013
Employees*
2-10
Funding to Date*
undisclosed
Website
quantumcyte.com
* Data source: Crunchbase
John Butler, CEO/CSO
I never intended on even giving a crap about cancer. It just happened. This isn’t a matter of me wanting to build a business, it’s a matter of wanting to help my wife.
1 in 4 patients don't receive conclusive biopsy results, largely due to low cell purity

QuantumCyte has developed an advanced AI-integrated platform for modern pathology to significantly improve patient outcomes. We combine digital pathology with the precise extraction of molecular data for solid tumor biopsies. We provide actionable, targeted results to help doctors reach conclusive diagnoses for their patients.